|
End-of-day quote
Buenos Aires S.E.
2026-09-04
|
5-day change | 1st Jan Change | ||
| 1,585.00 ARS | +1.60% |
|
+0.96% | -19.75% |
| Market Cap | 128B 84.93M 73.08M 68.76M 62.81M 117M 8.02B 118M 812M 315M 4.11B 319M 312M 13.25B | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 359B 238M 205M 193M 176M 330M 22.49B 330M 2.28B 884M 11.54B 895M 875M 37.18B | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
| 1 day | +1.60% | ||
| 1 week | +0.96% | ||
| Current month | -1.55% | ||
| 1 month | +3.26% | ||
| 3 months | -2.76% | ||
| 6 months | +1.60% | ||
| Current year | -19.75% |
| 1 week | 1,530 | 1,615 | |
| 1 month | 1,495 | 1,615 | |
| Current year | 1,420 | 2,130 | |
| 1 year | 945 | 2,300 | |
| 3 years | 480.5 | 2,300 | |
| 5 years | 215 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 2025-04-28 | |
| Corporate Officer/Principal | - | 2025-04-28 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.60% | +0.96% | +38.43% | +176.13% | 84.93M | ||
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | ||
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | ||
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | ||
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | ||
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | ||
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | ||
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | ||
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | ||
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | ||
| Average | -0.68% | +0.83% | +29.63% | +64.71% | 367.85B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 91.79B 60.91M 52.41M 49.31M 45.05M 84.27M 5.75B 84.5M 583M 226M 2.95B 229M 224M 9.51B | 127B 84.09M 72.36M 68.08M 62.19M 116M 7.94B 117M 804M 312M 4.07B 316M 309M 13.12B |
| Net income | 23.85B 15.82M 13.61M 12.81M 11.7M 21.89M 1.49B 21.95M 151M 58.74M 766M 59.41M 58.12M 2.47B | 3.09B 2.05M 1.76M 1.66M 1.52M 2.83M 193M 2.84M 19.6M 7.61M 99.25M 7.69M 7.53M 320M |
| Net Debt | 134B 88.68M 76.31M 71.79M 65.58M 123M 8.37B 123M 848M 329M 4.3B 333M 326M 13.84B | 231B 153M 132M 124M 113M 212M 14.47B 213M 1.47B 569M 7.43B 576M 563M 23.92B |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | ARS 1,585.00 | +1.60% | 3,631 |
| 26-09-03 | ARS 1,560.00 | -1.58% | 1,635 |
| 26-09-02 | ARS 1,585.00 | +2.26% | 1,189 |
| 26-09-01 | ARS 1,550.00 | -3.73% | 1,659 |
| 26-08-31 | ARS 1,610.00 | +2.55% | 5,467 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions
















